United States-based HealthGrowth Capital announced on Friday that it has named George Fencl as its new chief marketing officer, effective immediately.
Fencl brings senior strategic and tactical deployment experience from years at Y&R in New York and specialty agency Giant Creative Strategy in San Francisco. He has been interim CMO since HealthGrowth Capital's founding in 2016. As VP of Digital Strategies and Analytics at Giant Creative in San Francisco, he advised pharmaceutical companies, such as Amgen, J&J, Genentech and Abbott, to launch some of the successful products of the past decade.
Karl Kipke, chief executive officer of HealthGrowth Capital, said, 'George has been an invaluable resource in providing marketing guidance and insights over the past two years. George brings healthcare and pharmaceutical marketing expertise that folds perfectly into HealthGrowth's expanding financial products and advisory service offerings. We could not be happier to have him joining our team in this senior capacity.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer